Theranostics Health Signs Research Collaboration Agreement
News May 16, 2008
This relationship will provide Duke Investigators access to the company's core technologies: Laser Capture Microdissection (LCM) and Reverse Phase Protein Microarray (RPMA).
The proprietary combination of these technologies provides a powerful mechanism to measure the aberrant protein signaling and protein molecular networks used by tumor cells obtained directly from a patient's biopsy. This information can be used to investigate patient-specific treatments and individual treatment regimens, and also, to understand the mechanisms of tumorigenesis in order to discover and develop new, safer and more effective therapies.
According to Dr. Neil Spector, Director of Duke's Translational Research Oncology Program, "those of us at Duke who are going to participate in this umbrella agreement with Theranostics Health are excited about the insight this collaboration may provide on the use of phosphoproteomics to shed light on the complexities of the signaling networks that regulate tumor cell growth, survival, migration/invasion, and resistance to targeted therapies. We are intrigued by the possibility of applying this information to investigate more effective therapies for our patients."
Dr. Danong Chen, President and CEO of Theranostics Health, is equally optimistic about the master research agreement with Duke. "We are very pleased to begin collaboration with a nationally-recognized center of excellence and believe that Duke shares our vision of shaping a new paradigm in disease management. This relationship demonstrates the value of this technology for impacting healthcare delivery."
The BuzzBuster: Could Gene Silencing Help Silence the Housefly?News
Gene silencing dsRNA technology can reduce housefly fertility, showing promise as a pest-control method.READ MORE
Researchers Zoom in on DNA Code Being Read in CellsNews
Scientists have unveiled incredible images of how the DNA code is read and interpreted – revealing new detail about one of the fundamental processes of life. The mechanism for reading DNA and decoding it to build proteins for their needs is common to all animals and plants, and is often hijacked by cancer. The discovery of exactly how the molecular mechanism works, could open up new approaches to cancer treatment.READ MORE
LogicTRN Model Illuminates Regulatory Gene FrameworkNews
A newly devised algorithm called LogicTRN has the potential to unravel the complexities of genetic regulation.READ MORE